BARD1 Life Sciences Ltd. said nonexecutive director Geoffrey Laurent died Aug. 12.
Laurent joined the Australian cancer drug developer's board in 2016.
Discover more about S&P Global’s offerings
BARD1 Life Sciences director dies
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes
BARD1 Life Sciences Ltd. said nonexecutive director Geoffrey Laurent died Aug. 12.
Laurent joined the Australian cancer drug developer's board in 2016.